The anlyst continues to view Teladoc as a differentiated asset given its broad scale and optionality from recent acquisitions. ・Teladoc announced a CFO transition and reaffirmed its full year outlook ...

If you own Teladoc Health stock, or you are thinking about picking some up after the recent headlines, you are far from alone in wondering what comes next for this digital health pioneer. After a ...

Teladoc Health is offering a new employee assistance program (EAP) that leverages the mental health counseling of BetterHelp. EAPs are designed to support employees in short-term times of need. The ...

The solution supports a variety of applications, including workplace safety interventions and virtual sitting.

However, Teladoc has not performed well since it reached its all-time high in early 2021, and since then, the stock is down by 96%. Is the telemedicine specialist finally attractive at current levels, ...

Citron Research sees Teladoc as a bargain ready to rip higher, citing the end of this government shutdown as a bullish catalyst. While Citron's favorite catalyst seems questionable, Teladoc's bargain ...

For the third quarter, Teladoc expects to report revenue of $626.4 million and adjusted earnings before interest, taxes, depreciation and amortization of $69.9 million. Analysts polled by FactSet ...

Cash flow from operations totaled $15.9 million in the quarter. The company said capital expenditures and capitalized software development costs came in at $31.6 million. Teladoc ended the period with ...

Teladoc faces slow revenue growth (at best), constant net losses, and steep competition. Sarepta Therapeutics' most important product, a gene therapy, is under intense scrutiny. 10 stocks we like ...

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, ...